InCrowd Novel Coronavirus (COVID-19) Vaccine Development – Wave 3

Given the recent roll-out of the COVID-19 vaccine across the US, InCrowd conducted its third wave of research on perceptions and observations of infectious disease experts on the COVID-19 vaccine to gauge progress and perceptions. This report compares recent findings on efficacy, impact, and recommendations related to the COVID-19 vaccine with data from earlier in the year.*

* Please note, views in this survey reflect opinions only as reported by responding physicians.

Methodology:

• Method:
  • 10-Minute MicroSurvey via InCrowd
• Crowds:
  • Infectious disease doctors
• Sample Size:
  • n = 101
    • Community Hospital, Academic Hospital, Office-based
• Fielding Period:
  • January 21st – 22nd

InCrowd’s other COVID-19 Tracking Reports:

• InCrowd Novel Coronavirus (COVID-19) Frontline-Treating Physician Tracking Report – Wave 7
• Perceptions on 2020 Vaccines Against Influenza and COVID-19
• InCrowd Novel Coronavirus (COVID-19) Vaccine Development – Wave 2
• Non-Frontline Specialist Tracking Report – Wave 2